5 ms·
Insulin has been manufactured for decades, and is made by more than one company. Why are the prices rising?
by whatshisface 8y ago
Insulin has been manufactured for decades, and is made by more than one company. Why are the prices rising?
- RcouF1uZ4gsC 8y agoNot all insulins are the same. My guess is that this insulin is glargine (https://en.wikipedia.org/wiki/Insulin_glargine https://en.wikipedia.org/wiki/Insulin_glargine) which just came off of patent in 2015. Glargine is a synthetic long-acting form of insulin that gives allows absorption without peaks, which is much better than previous types of long-acting insulins.
- ng12 8y agoShort acting is the biggest problem. There's no generic for it.
- echlebek 8y agoMy understanding is that there are insulin analogs that are vastly better treatments, due to being faster acting. These analogs are still patented. However, even considering the patents, insulin prices for the same product are much higher in the USA than in Mexico or Canada. American prices have increased by an order of magnitude. [1] IMO this rampant price gouging can only be explained by the pharmaceutical lobby, and a political apparatus addicted to their money. [1] https://www.washingtonpost.com/news/wonk/wp/2016/10/31/why-insulin-prices-have-kept-rising-for-95-years/?noredirect=on&utm_term=.318cf26db23b https://www.washingtonpost.com/news/wonk/wp/2016/10/31/why-i...
- deleted 8y ago[deleted]
- whatshisface 8y agoIt sounds like the solution should be that patients can opt for cheaper, worse treatments, if they do not like that the more recent treatments are also more expensive.
- echlebek 8y agoWhy? Why should people have to pay inflated prices for treatments that have been standard since the 90s? Edit: just to be clear, the price of Humalog, a patented analog, has increased in price by 700% in the last 20 years. This is not simply a case of newer treatments being more expensive.
- ng12 8y agoThe short answer is patents. There's a cartel of a few makers (Novo-Nordisk, Lily and Sanofi) that slightly "improve" their insulin every few years to extend the patents. There are some generics available but they're not the fast-acting kind most diabetics use.
- noir_lord 8y agoThe perverse one is where the new patented version is only marginally more effective but 5x the price and they stop making the old one. It's a sick system.
- koolba 8y agoIs the new, still under patent, insulin that much better than what would be available to a generic manufacturer? If the previous generation would work for plenty of patients that’s a huge market opportunity.
- SamReidHughes 8y agoWhat do you mean extend the patents? Making a new version of insulin prevents the older version from going out of patent?
- deleted 8y ago[deleted]
- jahewson 8y agoUnlike most drugs insulin is derived from animal cells so it’s not really possible to make a generic because you can’t demonstrate that your end product is identical to an existing product (at least not as far as the FDA is concerned). The formulations are constantly tweaked by manufacturers to evergreen the patents too. New patents allow the price to be pushed up without risking new competition arriving.
- acdha 8y agoInsulin has been produced by bacteria since the 1980s when recombinant DNA techniques became viable. That’s very precisely controllable compared to the historic animal sources.
- fzeroracer 8y agoBecause endless profit growth is the only thing that matters regardless of the morality or reality of the situation. And what better market to exploit than one where most people have to make a decision between being priced gouged or death. This is of course an extremely simplistic way of looking at it but the reality is that we allow companies to abuse the patent system (under the guise of making research profitable for profiteering medical research) making generics impossible for things such as Insulin.
- KorematsuFred 8y agoMost insulin companies are not really making endless profit growth. They are very profitable but not by as much as you think. Secondly, no one runs a business of charity. Can't really blame them if they want to make huge profit by offering you something you really want. The real solution here is that FDA needs to close the loopholes on the patents that help them renew patents indefinitely. Secondly, drug import must be simplified from countries like Canada, China and Mexico for personal consumption. Third, people should opt for cheaper alternatives which might be slightly less effective than cutting edge.
- fzeroracer 8y agoI just wanted to start by addressing this one really disengenous comment >Can't really blame them if they want to make huge profit by offering you something you really want This isn't a company offering you something you really want. This is a company gouging the prices on something you literally need to live. So allow me to call you out on that shitty argument, first of all. And second, many people don't have the option to opt for cheaper alternatives. They have one choice, which often leads to people having to ration their insulin and die from it [1]. So I would highly recommend you actually do some reading up on the situation before you make claims about alternatives. [1] https://www.npr.org/sections/health-shots/2018/09/01/641615877/insulins-high-cost-leads-to-lethal-rationing https://www.npr.org/sections/health-shots/2018/09/01/6416158...
- KorematsuFred 8y ago
- refurb 8y agoThe actual price the manufacturer charges hasn't been going up much. Novolog list and net prices show Novolog vial has gone up 36% in price since 2001 (less than inflation) and Novolog Pen has gone up 3% since 2001.[1] [1] https://www.drugchannels.net/2016/12/novo-nordisk-sheds-new-light-on-pbm.html https://www.drugchannels.net/2016/12/novo-nordisk-sheds-new-...